Analyst IMS Investment Management Services Ltd.
CIK 1634208
13F filing for Q2 2026・No. 1,009
- Holdings
- US$4.3B
- Quarter change
- +US$1B
- Entries
- 223
- Net bought (estimate)
- +US$331.52M
This quarter was filed in thousands of dollars (dollars are required since 2023); multiplied by 1,000 here.
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 26
- Sold out 18
- Cut 56
- Added 21
- Corporate actions 0
- Unchanged 49
Largest holdings
152 stocks worth US$4.3B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| QQQInvesco QQQUNIT SER 1 | Added | 1,787,559 | US$1.32B | 30.59% |
| SPYTATE STR SPDR S&P 500 ETF TTR UNIT | Cut | 813,427 | US$607.44M | 14.12% |
| VOOVanguard S&P 500 ETFS&P 500 ETF SHS | Cut | 558,871 | US$383.84M | 8.92% |
| ISHARES TRISHARES SEMICDTR | Added | 571,693 | US$366.32M | 8.51% |
| ISHARES TRMSCI AC ASIA ETF | Added | 2,384,364 | US$284.53M | 6.61% |
| IVVISHARES TRCORE S&P500 ETF | Cut | 293,062 | US$219.47M | 5.10% |
| 2684211DTEVA PHARMACEUTICAL INDS LTDSPONSORED ADS | Unchanged | 2,116,302 | US$71.7M | 1.67% |
| VWOVANGUARD INTL EQUITY INDEX FFTSE EMR MKT ETF | Added | 1,139,643 | US$68.03M | 1.58% |
| FIDELITY COMWLTH TRNASDAQ COMPSIT | Cut | 498,898 | US$51.5M | 1.20% |
| EWYSHARES INCMSCI STH KOR ETF | New | 248,131 | US$50.1M | 1.16% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled July 29, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.